This study assesses the effects of a probiotic or postbiotic on gut microbiome during antibiotic treatment.
Males and females aged ≥18 to ≤ 65 years; if female, either not of childbearing potential or using a medically approved method of birth control and willing to take a pregnancy test at screening.
Body mass index (BMI) 18.5-29.9 kg/m².
Healthy as determined by medical history and physical examination.
Agreed not to change current dietary habits during the course of the study.
Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the study.
People on vegetarian or vegan diet; People on special diet (e.g. Ducan, Keto, etc.)
BMI ≥ 30 kg/m² or <18.5 kg/m².
History of intake of antibiotics, other probiotics, postbiotics, prebiotics, synbiotics, proton pump inhibitors, acid sequestrants (cholestyramine, Bile colestipol), within six months prior to the screening day.
The Archer-Daniels-Midland Company
Lead sponsor
NEXT CRO
Collaborator